Explore more topics
News sentiment

Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) news sentiment

How positive or negative Rhythm Pharmaceuticals, Inc. Common Stock's news headlines have been since Sep 23, 2019, week by week, with the last 90 sessions day by day and each recent headline's tone and source.

As of 2026-11-06

Average tone, last 30 sessions
+11From -100 (every headline negative) to +100 (every headline positive)
Headlines, last 30 sessions
16
Headlines, last 90 sessions
37
Change from the 90-session average
-12
Latest session
2026-11-06

Weekly headline tone since September 2019

Hover a week for its biggest stories; click to pin.

Tone8-week averageHeadlinesFiltered out (passing mentions)
Every week since Sep 23, 2019
RYTM headline tone: Every week since Sep 23, 2019, 246 weeks from September 23, 2019 to October 19, 2026.-100-75-50-25+25+50+75+1000Headlines2020202120222023202420252026

Coverage of Rhythm Pharmaceuticals, Inc. Common Stock over the last 30 trading sessions is positive (+11) across 16 headlines, 19 points below its one-year average of +30. The most widely carried story in the week of Oct 19, 2026 was "Comparing ADMA Biologics (NASDAQ:ADMA) & Rhythm Pharmaceuticals (NASDAQ:RYTM)", carried by 1 outlet.

Each point is one week of headlines about Rhythm Pharmaceuticals, Inc. Common Stock: the share of positive minus negative headlines, from -100 to +100, with the 8-week average drawn through it and the number of headlines beneath. Since coverage began, 685 headlines average +31.

Jump to a section

Tone mix

RYTM headlines by tone, last 52 weeks
positive
40%
neutral
52%
negative
9%

Week by week 51 weeks

Aug 4, 2025: 3 positive, 1 neutral, 0 negativeAug 11, 2025: 0 positive, 2 neutral, 0 negativeAug 18, 2025: 2 positive, 0 neutral, 0 negativeAug 25, 2025: 0 positive, 1 neutral, 0 negativeSep 1, 2025: 2 positive, 0 neutral, 0 negativeSep 15, 2025: 1 positive, 0 neutral, 0 negativeSep 29, 2025: 3 positive, 0 neutral, 0 negativeOct 6, 2025: 1 positive, 0 neutral, 0 negativeOct 20, 2025: 0 positive, 2 neutral, 0 negativeNov 3, 2025: 2 positive, 3 neutral, 1 negativeNov 10, 2025: 0 positive, 4 neutral, 1 negativeNov 17, 2025: 1 positive, 1 neutral, 0 negativeDec 1, 2025: 0 positive, 1 neutral, 0 negativeDec 8, 2025: 6 positive, 2 neutral, 0 negativeDec 15, 2025: 3 positive, 1 neutral, 0 negativeDec 22, 2025: 1 positive, 3 neutral, 0 negativeDec 29, 2025: 0 positive, 0 neutral, 1 negativeJan 5, 2026: 0 positive, 3 neutral, 0 negativeJan 12, 2026: 2 positive, 1 neutral, 0 negativeJan 26, 2026: 1 positive, 1 neutral, 0 negativeFeb 2, 2026: 0 positive, 1 neutral, 0 negativeFeb 9, 2026: 0 positive, 4 neutral, 0 negativeFeb 16, 2026: 2 positive, 6 neutral, 0 negativeFeb 23, 2026: 2 positive, 3 neutral, 1 negativeMar 2, 2026: 1 positive, 1 neutral, 1 negativeMar 9, 2026: 0 positive, 1 neutral, 0 negativeMar 16, 2026: 1 positive, 1 neutral, 5 negativeMar 23, 2026: 3 positive, 0 neutral, 0 negativeApr 6, 2026: 0 positive, 3 neutral, 0 negativeApr 27, 2026: 1 positive, 0 neutral, 0 negativeMay 4, 2026: 3 positive, 3 neutral, 0 negativeMay 11, 2026: 1 positive, 0 neutral, 0 negativeMay 25, 2026: 0 positive, 2 neutral, 0 negativeJun 1, 2026: 0 positive, 1 neutral, 0 negativeJun 8, 2026: 0 positive, 1 neutral, 0 negativeJun 15, 2026: 2 positive, 4 neutral, 0 negativeJun 22, 2026: 0 positive, 2 neutral, 0 negativeJun 29, 2026: 1 positive, 0 neutral, 0 negativeJul 6, 2026: 1 positive, 0 neutral, 0 negativeJul 20, 2026: 0 positive, 1 neutral, 0 negativeJul 27, 2026: 0 positive, 1 neutral, 0 negativeAug 3, 2026: 3 positive, 3 neutral, 0 negativeAug 10, 2026: 2 positive, 1 neutral, 0 negativeAug 17, 2026: 1 positive, 3 neutral, 0 negativeAug 24, 2026: 1 positive, 0 neutral, 0 negativeSep 14, 2026: 1 positive, 0 neutral, 2 negativeSep 21, 2026: 0 positive, 1 neutral, 0 negativeSep 28, 2026: 0 positive, 2 neutral, 0 negativeOct 5, 2026: 1 positive, 0 neutral, 0 negativeOct 12, 2026: 1 positive, 0 neutral, 0 negativeOct 19, 2026: 0 positive, 2 neutral, 0 negative
Aug 4, 2025Oct 19, 2026

Share of Rhythm Pharmaceuticals, Inc. Common Stock's 141 headlines over the last 52 weeks by the model's call, and the same mix week by week.

Biggest swings in the last year

The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.

Daily headline tone, last 90 sessions

Hover a session for its totals; click to pin.

Session tone8-session averageHeadlines
Last 25 sessions with a headline
RYTM average headline tone by session: Last 25 sessions with a headline, 25 sessions from July 9, 2026 to November 6, 2026.-100-75-50-25+25+50+75+1000HeadlinesJul 2026AugSepOctNov

Each point is the average score of the headlines about Rhythm Pharmaceuticals, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.

Tone by period

Show the table · 3 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Last 7 sessions10-2
Last 30 sessions16+11
Last 90 sessions37+23

Every headline in the period counts equally.

Headlines on Friday, November 6, 2026

1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Rhythm Pharmaceuticals (NASDAQ:RYTM) Sees Strong Trading Volume on Analyst Upgradewww.tickerreport.com1Positive

Headlines on Thursday, November 5, 2026

2 headlines, average tone -42: 0 positive, 1 neutral and 1 negative. Showing all 2.

Show the table · 2 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Crosses Above 200 Day Moving Average Following Analyst Downgradewww.tickerreport.com1Negative
Rhythm Pharmaceuticals changes its tune with LG Chemwww.bioxconomy.com1Neutral

Headlines on Wednesday, November 4, 2026

4 headlines, average tone -25: 0 positive, 3 neutral and 1 negative. Showing all 4.

Show the table · 4 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Rhythm Pharma (RYTM) Q3 2026 Earnings Call Transcriptwww.aol.com2Neutral
Rhythm Pharmaceuticals Stock Slips 11% On Announcement Of Q3 Reportwww.rttnews.com1Negative
Rhythm Pharmaceuticals Q3 Earnings Call Highlightswww.dailypolitical.com1Neutral
Rhythm Pharmaceuticals (NASDAQ:RYTM) Issues Earnings Resultswww.themarketsdaily.com1Neutral

Headlines on Tuesday, November 3, 2026

2 headlines, average tone +34: 1 positive, 1 neutral and 0 negative. Showing all 2.

Show the table · 2 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreementwww.manilatimes.net1Positive
Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Updatewww.manilatimes.net1Neutral

Headlines on Monday, November 2, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Contrasting Janux Therapeutics (NASDAQ:JANX) & Rhythm Pharmaceuticals (NASDAQ:RYTM)www.dailypolitical.com1Neutral

How the score works

A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.

  1. Which headlines count

    Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Rhythm Pharmaceuticals, Inc. Common Stock, not a passing mention.

  2. How each headline is scored

    The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).

  3. When a headline counts

    Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.

  4. Repeated stories

    When several outlets carry the same headline, it counts once per session.